Back to search results
NCT07618273

Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

Recruiting
NAAges 18–44InterventionalScreening
Mayo Clinic
~50 participants
Updated 2026-06-05 on ClinicalTrials.gov
What's tested:Artificial Intelligence-based InterventionBest PracticeCommunication InterventionQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in gastrointestinal self-advocacy
Measured over At baseline and at 4 weeks

Conditions

Colorectal Carcinoma

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Janice Krieger, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Enhancing Technology & Communication in Healthcare (ETCH) Lab
[email protected]
904-953-5375
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ages 18-44 years
Concerned about their GI health
Able to speak and read English
Willing to complete a four-week symptom tracking protocol

Exclusion

Unable to understand the informed consent or comply with protocol requirements

What this trial measures

  • Change in gastrointestinal self-advocacyAt baseline and at 4 weeks

    Will use a 4-items self-report "How confident are you in..." scale and chart-verified data to assess baseline and post-intervention self-advocacy. Questions are answered on a 5-point scale where 1=not at all confident and 5=extremely confident. Higher scores indicate greater self-advocacy confidence. Will compare mean change between arms using analysis of covariance (ANCOVA) or linear regression adjusting for baseline scores. Will estimate effect sizes (Cohen's d) and 95% confidence intervals. Sensitivity analysis will use mixed-effects models for repeated measures.